Sign In
Buy PDEX
$65.17
-1.58 (-2.37%)
At Close: Jun 03, 2026
Pro-Dex: Still A Buy, But Don't Chase
07:06am, Friday, 15'th May 2026
Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their AP
Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
04:00pm, Thursday, 30'th Apr 2026
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average – Should You Sell?
02:27am, Saturday, 28'th Mar 2026
Shares of Pro-Dex, Inc. (NASDAQ: PDEX - Get Free Report) passed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $38.09 and traded a
Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
04:00pm, Thursday, 12'th Feb 2026
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), for
Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
04:00pm, Thursday, 29'th Jan 2026
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025.
Head-To-Head Contrast: Pro-Dex (NASDAQ:PDEX) vs. STAAR Surgical (NASDAQ:STAA)
02:51am, Wednesday, 28'th Jan 2026
Pro-Dex (NASDAQ: PDEX - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two busine
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
01:05am, Saturday, 17'th Jan 2026
Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This means that PDEX effectively combines OEM programs with a smaller catalog of industrial offerings. H
D.A. Davidson & CO. Increases Holdings in Pro-Dex, Inc. $PDEX
04:07am, Monday, 12'th Jan 2026
D.A. Davidson and CO. boosted its stake in Pro-Dex, Inc. (NASDAQ: PDEX) by 152.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Comm
Pro-Dex Valuation Is Attractive Despite Customer Risk
05:24pm, Thursday, 08'th Jan 2026
Pro-Dex Inc. is a specialized surgical device manufacturer with strong growth, efficient capital allocation, and high customer concentration risk. PDEX trades at ~16x recurrent earnings, which is fair
Head to Head Survey: Cardinal Health (NYSE:CAH) vs. Pro-Dex (NASDAQ:PDEX)
02:48am, Monday, 05'th Jan 2026
Cardinal Health (NYSE: CAH - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on
Head-To-Head Review: Pro-Dex (NASDAQ:PDEX) & Spotlight Innovation (OTCMKTS:STLT)
05:20am, Sunday, 28'th Dec 2025
Pro-Dex (NASDAQ: PDEX - Get Free Report) and Spotlight Innovation (OTCMKTS:STLT - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses b
Pro-Dex, Inc. Announces Contract Extension With Largest Customer
04:00pm, Friday, 19'th Dec 2025
IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on December 17, 2025, it executed a contract amendment with its largest customer for an additional
Head to Head Contrast: Spotlight Innovation (OTCMKTS:STLT) versus Pro-Dex (NASDAQ:PDEX)
02:11am, Friday, 12'th Dec 2025
Spotlight Innovation (OTCMKTS:STLT - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses
Head to Head Review: Pro-Dex (NASDAQ:PDEX) vs. Lifevantage (NASDAQ:LFVN)
02:34am, Tuesday, 18'th Nov 2025
Lifevantage (NASDAQ: LFVN - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies
Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top Estimates
06:36pm, Thursday, 30'th Oct 2025
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.75 per share a year ago.
